CML Study IV of CML: long-term observation of 1151 patients from the randomized Impact of additional cytogenetic aberrations at diagnosis on prognosis

doi:10.1182/blood-2011-08-373902Prepublished online October 28, 2011;2011 118: 6760-6768€€€€the German CML Study GroupHehlmann and for the Schweizerische Arbeitsgemeinschaft fur Klinische Krebsforschung (SAKK) andBaerlocher, Michael Lauseker, Markus Pfirrmann, Joerg Hasford, Susanne Saussele, Rudiger Stegelmann, Michael Pfreundschuh, Cornelius F. Waller, Karsten Spiekermann, Gabriela M.Einsele, Anthony D. Ho, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Jung-Munkwitz, Ulrike Proetel, Juliana Schwaab, Wolf-Karsten Hofmann, Jorg Schubert, HermannHaferlach, Gudrun Gohring, Brigitte Schlegelberger, Martine Jotterand, Andreas Reiter, Susanne Alice Fabarius, Armin Leitner, Andreas Hochhaus, Martin C. Muller, Benjamin Hanfstein, Claudia€